Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Quantification of H3.1-nucleosomes using a chemiluminescent immunoassay: A reliable method for neutrophil extracellular trap detection

Thursday, August 7, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses a new method for quantifying H3.1-nucleosomes using a chemiluminescent immunoassay. This technique is presented as a reliable approach for detecting neutrophil extracellular traps, which are important in various diseases. The research aims to improve the understanding of neutrophil functions and their implications in health and disease.
Price reaction · baseline $13.36 (2025-08-06 close) · hit pre-market · 2 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-4.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduces a reliable method for detecting neutrophil extracellular traps.
  • Utilizes a chemiluminescent immunoassay for quantification.
  • Potentially enhances understanding of neutrophil activity in diseases.

Full Press Release Details

Paper titled: Quantification of H3.1-nucleosomes using a chemiluminescent immunoassay: A reliable method for neutrophil extracellular trap detection
Marion Wargnies, Guillaume Rommelaere, Julie Candiracci, Dorian Pamart, Robin Varsebroucq, Florian Jibassia, Finley Serneo, Virginie Laloux, Olivia Thiry, Fanny Lambert, Alison Lobbens, Priscilla Van den Ackerveken, Marielle Herzog
Published in Plos One

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the purpose of the new method discussed?

The method aims to reliably quantify H3.1-nucleosomes for detecting neutrophil extracellular traps.

What type of assay is used in this research?

A chemiluminescent immunoassay is utilized for the quantification process.

Who are the authors of the paper?

The paper is authored by Marion Wargnies and colleagues.

Where was the research published?

The research was published in the journal Plos One.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare H3.1-nucleosomes neutrophil extracellular traps chemiluminescent immunoassay Volition sepsis
Last updated: Aug 7, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk